Health

Subterms

    More stories

    • 50 Shares149 Views

      in World Politics

      Where India Went Wrong

      by

      In just over a month, India has gone from boasting about its vaccine diplomacy to becoming the global epicenter of the COVID-19 pandemic. As this author explained in a previous article, many have questioned whether India’s vaccine diplomacy was a bold masterstroke or an unwise distraction.

      Before the start of the second wave of COVID-19 infections in March, the pandemic seemed to be under control in India. In September 2020, the country recorded an average of 95,000 daily cases of COVID-19 during the peak of the first wave. By January 2021, that figure had dropped to under 20,000.

      At the same time, the United States went from around 35,000 confirmed cases per day in September to a peak of over 300,000 in January. At the start of the year, the United Kingdom was in the midst of a deadly second wave of infections, which reached over 60,000 cases a day. At that time, Britain was battling a more contagious strain of COVID-19 known as the “Kent variant,” which is named after the region where it was first discovered in England. Countries in Europe and around the world raced to halt flights to and from the UK in a bid to control the spread of the new strain, which they feared would soon go beyond the British isles.

      India’s Health-Care System Is in Shambles

      READ MORE

      To put these figures in perspective, the UK population is 66.6 million, the US is 328 million and India is around 1.36 billion. That means at the start of 2021, the infection ratio per 100,000 people in India was far lower than in the UK and the US.

      Lax Safety Measures

      As a result, Indians thought the country was beyond the worst of the pandemic. In March, Harsh Vardhan, the Indian health minister, said the country had entered the “endgame” of the health crisis. This led to a false sense of hope, which made the public and the central and state governments complacent. Restrictions that were brought in to curb the spread of the coronavirus were quickly eased. Life had almost returned to normal in January with the opening up of nightclubs, restaurants, hotels, tourist locations and public transport.

      At the same time, elections were announced in five states, including West Bengal, which the ruling Bharatiya Janata Party (BJP) had set its sights on winning. All political parties and their supporters held rallies with tens of thousands of people in attendance. The Hindu festival of Kumbh Mela attracted millions of people who took a dip in the Ganges, a river considered sacred in Hinduism. Nearly 60,000 spectators were also allowed to enter stadiums to watch cricket matches. All of these events took place with lax safety measures in place, with no social distancing or wearing of masks.

      Embed from Getty Images

      In hindsight, India did not anticipate a second wave of COVID-19. It lifted the lid on public restrictions at a time when countries such as the UK were battling a winter wave of infections. As mainland Europe realized, it was inevitable that the more contagious strain of COVID-19 discovered in the UK would spread. India failed to realize this despite repeated warnings.

      Now, India is battling its own second wave. The country has repeatedly broken the record for the daily number of confirmed cases of COVID-19. On May 2, India recorded more than 400,000 new daily infections. The actual number of cases is believed to be far higher due to a shortage of testing kits and people getting tested. Many Indians are not getting checked because they have no symptoms but are contagious or they are worried about testing positive for the virus. States like Bihar, West Bengal and Maharashtra have been accused of manipulating and underreporting the number of positive cases and deaths from COVID-19 to avoid criticism over inefficient governance. Worryingly, epidemiologists believe that India has not yet hit the peak of the second wave and that the worst is yet to come.

      No Improvement to Health Care

      It has been argued by many that the pandemic will not come to an end until it is under control everywhere. This is because “viruses naturally mutate over time.” There are currently thousands of mutations of the coronavirus around the world, but only a few of them are variants of concern for scientists. As more people contract the virus and spread it to others, it is inevitable that different strains will emerge. This is why despite the successful vaccination rollout in countries like Israel, the UK and the US, authorities have been cautious as they reopen economies and reduce restrictions for the public. The fear is that some variants, such as the one discovered in South Africa, will evade the existing vaccines and render them less effective.

      India has discovered a worrying COVID-19 variant of its own that is officially called B.1.617. This new strain — which is also known as the “double mutant” due to two mutations coming together in the same variant — accounts for 61% of infections in Maharashtra, a major epicenter for infections. It is unclear whether the Indian variant is driving the second wave, but it is believed to be more transmissible than previous strains of the virus. This is in addition to fear over the UK strain, which has spread to more than 50 countries.

      Complacency by the central and state governments has made the health care system crumble as Indians desperately seek medical assistance. When the pandemic first hit India in March 2020, authorities failed to strengthen the infrastructure at hospitals. As of 2018, the Indian government spent only 3.54% of GDP on health care. Other emerging economies such as Brazil and South Africa spent 9.51% and 8.25%, respectively. In India, there is only one doctor per 1,445 people, which is far lower than the figure the World Health Organization recommends. At public hospitals, there were only 0.7 beds available per 1,000 people.

      .custom-post-from {float:right; margin: 0 10px 10px; max-width: 50%; width: 100%; text-align: center; background: #000000; color: #ffffff; padding: 15px 0 30px; }
      .custom-post-from img { max-width: 85% !important; margin: 15px auto; filter: brightness(0) invert(1); }
      .custom-post-from .cpf-h4 { font-size: 18px; margin-bottom: 15px; }
      .custom-post-from .cpf-h5 { font-size: 14px; letter-spacing: 1px; line-height: 22px; margin-bottom: 15px; }
      .custom-post-from input[type=”email”] { font-size: 14px; color: #000 !important; width: 240px; margin: auto; height: 30px; box-shadow:none; border: none; padding: 0 10px; background-image: url(“https://www.fairobserver.com/wp-content/plugins/moosend_form/cpf-pen-icon.svg”); background-repeat: no-repeat; background-position: center right 14px; background-size:14px;}
      .custom-post-from input[type=”submit”] { font-weight: normal; margin: 15px auto; height: 30px; box-shadow: none; border: none; padding: 0 10px 0 35px; background-color: #1878f3; color: #ffffff; border-radius: 4px; display: inline-block; background-image: url(“https://www.fairobserver.com/wp-content/plugins/moosend_form/cpf-email-icon.svg”); background-repeat: no-repeat; background-position: 14px center; background-size: 14px; }

      .custom-post-from .cpf-checkbox { width: 90%; margin: auto; position: relative; display: flex; flex-wrap: wrap;}
      .custom-post-from .cpf-checkbox label { text-align: left; display: block; padding-left: 32px; margin-bottom: 0; cursor: pointer; font-size: 11px; line-height: 18px;
      -webkit-user-select: none;
      -moz-user-select: none;
      -ms-user-select: none;
      user-select: none;
      order: 1;
      color: #ffffff;
      font-weight: normal;}
      .custom-post-from .cpf-checkbox label a { color: #ffffff; text-decoration: underline; }
      .custom-post-from .cpf-checkbox input { position: absolute; opacity: 0; cursor: pointer; height: 100%; width: 24%; left: 0;
      right: 0; margin: 0; z-index: 3; order: 2;}
      .custom-post-from .cpf-checkbox input ~ label:before { content: “f0c8”; font-family: Font Awesome 5 Free; color: #eee; font-size: 24px; position: absolute; left: 0; top: 0; line-height: 28px; color: #ffffff; width: 20px; height: 20px; margin-top: 5px; z-index: 2; }
      .custom-post-from .cpf-checkbox input:checked ~ label:before { content: “f14a”; font-weight: 600; color: #2196F3; }
      .custom-post-from .cpf-checkbox input:checked ~ label:after { content: “”; }
      .custom-post-from .cpf-checkbox input ~ label:after { position: absolute; left: 2px; width: 18px; height: 18px; margin-top: 10px; background: #ffffff; top: 10px; margin: auto; z-index: 1; }
      .custom-post-from .error{ display: block; color: #ff6461; order: 3 !important;}

      In July 2020, state governments opted to build temporary centers for COVID-19 patients instead of buying additional beds for existing hospitals and allocating more resources. These centers were barely used. Due to their high maintenance costs, they were dismantled a couple of months before the second wave hit. Now, as hospitals face a short supply of beds and a high demand for them, some state governments are considering whether to rebuild the makeshift centers.

      In March 2020, Modi allocated 150 billion rupees ($2.03 billion) to strengthen the infrastructure of health care in India. The government purchased personal protective equipment (PPE) and an additional 60,000 ventilators. Yet as of last fall, just under 24,000 of the ventilators had been installed in hospitals across the country. Both public and private hospitals are currently short of beds, ventilators and oxygen in many major cities.

      As COVID-19 infections sweep the country, social media networks have been flooded with posts calling for help. Friends and families of those suffering from the virus have desperately sought to find available beds in hospitals, oxygen supplies or medication to combat COVID-19. Disturbing reports of people dying after being unable to access treatment have been heard all over the country. Ambulances and other vehicles with COVID-19 victims inside them have lined up outside hospitals that no longer have space available. Many hospitals have reported that patients they were treating died as the oxygen supply ran out. Outside crematoriums, the number of dead bodies is mounting.

      The Government’s “Vaccine Diplomacy”

      With the situation worsening, the BJP-led government has been criticized by Indian courts for focusing on state election campaigns instead of taking preemptive action to combat the second wave. Aside from easing restrictions too quickly and not reinforcing the health care system in time, many states face shortages of COVID-19 vaccines. In January, Prime Minister Narendra Modi claimed to have rolled out the “world’s largest vaccination drive,” aiming to get jabs in the arms of 300 million people by July. At the time of writing, only 2% of the Indian population — 29 million — has been fully vaccinated with two doses. This is compared to 23% in the UK and 30% in the US, both of which focused on vaccinating their most vulnerable citizens first to drive down new infections and deaths.

      India had other things in mind. It sought to distribute doses worldwide as part of its vaccine diplomacy. With the world’s largest manufacturer of vaccines, India has so far exported 66 million doses to 95 countries. Yet, earlier this year, the Modi government implemented an initiative to donate free batches in an attempt to boost the country’s soft power when the pandemic was seemingly under control. Many observers questioned whether the move was necessary instead of focusing on vaccinating Indians themselves. Toward the end of March, as infections increased and vaccines decreased, the Modi government realized that its decision to export millions of doses was premature. It decided to halt the export of doses and instead vaccinate Indians over the age of 45. Yet the damage had already been done due to poor planning by the BJP-led government.

      Embed from Getty Images

      Meanwhile, state administrations in Maharashtra, Delhi and Andhra Pradesh that are not ruled by the BJP have claimed they are running short of vaccines. Critics have accused Modi of playing politics with vaccine distribution as states with BJP governments, such as Gujarat, were given almost the same number of vaccine doses as Maharashtra, which has a population double that of Gujarat. The health minister has denied that regions were short of supplies and instead blamed state governments for the poor rollout of vaccines.

      In order to counter criticism over its inefficient planning, the central government announced on April 19 that all citizens above 18 would be able to get vaccinated from May 1; it had previously focused on health and frontline workers and those over 45. By opening the door for all adults, an additional 600 million citizens are now eligible. Yet with vaccines in short supply, some states have postponed the rollout. The website through which citizens can book a jab crashed minutes after it went live for the new age group.

      The government has approved additional funds for vaccine manufacturers to ramp up production. However, the increased production is unlikely to be available for a few months as vaccines go through a lengthy process of packaging and safety checks. To make up for this shortage, the government has fast-tracked the approval process for foreign-produced vaccines. These include Johnson and Johnson from Belgium and Sputnik V from Russia, which cost more than domestically-produced ones.

      Public Image

      In an attempt to maintain his public image, Modi addressed the nation on April 20. Indians needed assurances and demanded answers, but the prime minister offered none. He neither informed the public about plans to tackle the crisis, nor did he give any reasons about why the country is facing a horrific second wave. This is despite him previously boasting that India’s handling of the pandemic had been exemplary and should a model for the world. It seems the central government is content with placing the blame on state administrations and the public instead of admitting that it made mistakes.

      Earlier this week, the BJP failed to win in the state of West Bengal despite heavy election campaigning. It seems that Indians are beginning to realize that Modi’s preoccupation with his public image, and his need to win votes, is costing the country dearly. In fact, the obsession with elections on the part of Indian politicians has contributed to the second wave of COVID-19 infections. India can only hope that Modi and other politicians shift their focus from politics to health care before it is too late.

      The views expressed in this article are the author’s own and do not necessarily reflect Fair Observer’s editorial policy. More

    • 125 Shares109 Views

      in US Politics

      Arizona passes sweeping anti-abortion bill banning procedure for genetic issues

      by

      Arizona’s governor has signed a sweeping anti-abortion bill that bans the procedure if the woman is seeking it solely because a fetus has a genetic abnormality such as Down’s syndrome.Doctors who perform an abortion solely because the child has a survivable genetic issue can face felony charges. The proposal also contains a raft of other provisions sought by abortion opponents.The measure passed the Republican-controlled legislature on party-line votes over unanimous opposition from minority Democrats. Doug Ducey, a Republican, is an abortion opponent who has never vetoed a piece of anti-abortion legislation.The abortion bill as originally written made it a felony for a doctor to perform the procedure because the fetus has a genetic abnormality such as Down’s syndrome, and contained a slew of other provisions, including one that confers all civil rights to unborn children. Democrats call that “personhood” provision a backdoor way to allow criminal charges against a woman who has an abortion.In addition to the ban on abortions for genetic abnormalities and the “personhood” provision, the bill bans mail delivery of abortion-inducing medication, allows the father or maternal grandparents of a fetus aborted because of a genetic issue to sue, and bans the spending of any state money toward organizations that provide abortion care.The measure also requires fetal remains to be buried or cremated, and it forbids state universities from providing abortion care.The measure was a top priority for the social conservative group Center for Arizona Policy. Its president, Cathi Herrod, routinely backs anti-abortion bills in the legislature. National anti-abortion groups hailed its passage.Minutes after the governor acted, Herrod sent out a news release with the subject line “Life Wins!”Pro-choice groups had rallied at the Capitol on Monday, urging Ducey to veto the measure and presenting him with petitions signed by opponents of the bill.Democrats lamented the governor’s action, including representative Diego Espinoza of Tolleson.“Governor Ducey’s decision to sign SB1457 is not pro-life. It is anti-families, anti-woman, and anti-doctor,” Espinoza tweeted. “I’m disappointed to see Arizona moving in this direction, ignoring the needs and desires of doctors, women, and families for an extreme political agenda.”Republican-controlled legislatures in Arizona and several other states – emboldened by the possibility that a more conservative US supreme court could overturn Roe v Wade, the 1973 decision that found women have a constitutional right to seek an abortion – have embraced proposals this year that could completely ban abortion. An Arizona proposal doing that, however, has not advanced. More

    • 188 Shares169 Views

      in US Politics

      Harry and Meghan to join Joe Biden at Vax Live concert to increase global vaccination

      by

      The Duke and Duchess of Sussex will join the US president, Joe Biden, at a concert in Los Angeles aimed at increasing the global vaccination effort.Harry and Meghan are “campaign chairs” of the A-list event, Vax Live. Hosted by Selena Gomez, and organised by Global Citizen, the event, on Saturday 8 May, will feature musical performances by names from the worlds of film and politics, and music performances from stars including Jennifer Lopez, Pearl Jam’s Eddie Vedder, Foo Fighters, J Balvin and HER.The broadcast special aims to encourage donations to Covax, which is working to provide vaccines for low and middle-income countries.In a statement, the Sussexes said: “Over the past year, our world has experienced pain, loss and struggle – together. Now we need to recover and heal – together. We can’t leave anybody behind. We will all benefit, we will all be safer, when everyone, everywhere has equal access to the vaccine.“We must pursue equitable vaccine distribution and, in that, restore faith in our common humanity. The mission couldn’t be more critical or important.”Special guests, including Ben Affleck, Chrissy Teigen, David Letterman, Gayle King, Jimmy Kimmel and Sean Penn, will speak from around the world.Biden, along with the US first lady, Jill Biden, and the vice-president, Kamala Harris, will make special appearances through Global Citizen’s partnership with the White House’s We Can Do This initiative, which encourages measures, including mask wearing.Appearances by the French president, Emmanuel Macron, the Canadian prime minister, Justin Trudeau, and the Croatian prime minister, Andrej Plenković, are also planned, organisers say.A trailer for Vax Live promised it would feature “big names and an even bigger message”. It will be recorded at SoFi stadium in Los Angeles, and air on 8 May across networks including ABC, CBS, and iHeartMedia radio stations.The announcement comes as there are calls for the US to hand over 60m doses of AstraZeneca vaccine to India as part of the global drive to fight the virus. The US announced on Monday that 60m doses would be available to send abroad once the vaccine was approved by the Food and Drug Administration (FDA).Global Citizen calls itself a movement of “engaged citizens who are using their collective voice to end extreme poverty by 2030”. The concert has been described as a call to world leaders to ensure vaccines are accessible for all. More

    • 88 Shares119 Views

      in World Politics

      Bill Gates and the Zero-Sum Vaccination Game

      by

      The debate is raging once again about the true origin of COVID-19. Was it zoonotic, originating in a bat cave and then infecting exotic meat in Wuhan’s wet market as the majority of scientists claimed throughout 2020? At the approach of the November election, US President Donald Trump preferred to believe the pandemic was a plot to destroy his presidency conducted by a man he previously called an intimate “friend,” China’s President Xi Jinping. The virus was already spreading when Trump explained to World Economic Forum in Davos the nature of his relationship with Xi: “He’s for China, I’m for the US, but other than that, we love each other.”

      Four months later, Trump began contradicting scientists and blaming Xi’s China by claiming “that the virus originated in a laboratory and was accidentally released.” In September, he preferred to suggest to his voters that COVID-19 was the result of an Asian conspiracy designed to undermine his presidency. This sparked a wave of anti-Asian attacks in the US that have continued to this day.

      Prominent scientists today recognize that Trump’s initial assessment may have been right. Their colleagues who dismissed the idea of an accidental release of the virus from a Wuhan laboratory were either misled or disingenuously defensive of an equally unproven thesis. The scientists may have been impelled to reject the suspicion of a laboratory accident not only out of a lack of direct evidence, but also out of fear of the political blame game the president was beginning to exploit to distract attention from his own failure to respond appropriately to the crisis.

      Trump obviously preferred to see the war against a virus as a PR opportunity to bolster his image as a fearless leader. Allowing politicians to place blame on China, even for an accident, might have become as dangerous for the world as the virus itself, adding to the reigning misery rather than resolving the mystery of the origin of the disease.

      Wealth Inequality Breeds Health Inequality

      READ MORE

      Science itself and its public image have taken a hit from this ongoing catastrophe. The honored, if not revered Dr. Anthony Fauci admitted to prioritizing the distribution of masks among the medical community above the general public at a time when little was still known about how contagious COVID-19 was and how it spread. Political leaders across the globe, including Trump, all found themselves in a thankless position as they were required to demonstrate their leadership with insufficient knowledge of the nature of the challenge and a penury of material means to confront it.

      Many deserve to share the blame for a situation that, despite progress with vaccines, is still in many ways worsening. But, as Alexander Zaitchik exposes in an important article in The New Republic, the person perhaps most to blame for our global failure to respond effectively is neither a scientist nor a politician. His name is Bill Gates.

      Most rational people would reason that a global crisis requires a global response. Most realists recognize that in a civilization dominated by sovereign nation-states, summoning a unified response to any global crisis will never be easy. Humanity’s quasi-universal awareness of the problem of global warming over the decades demonstrates the difficulty of mobilizing humankind to implement even a minimalist response.

      In his article, “How Bill Gates Impeded Global Access to Covid Vaccines,” Zaitchik narrates a depressing story that began in February 2020, when the nature of the COVID-19 threat had become clear. In conformity with its mission, the World Health Organization (WHO) coordinated a “research and innovation forum to mobilize international action” aimed at combating the spreading epidemic. It sought to “maintain broad and open channels of communication, since collaboration and information-sharing minimize duplication and accelerate discovery.”

      Collaboration and sharing of science would be critical to any effective response. With most research publicly funded — a point Mariana Mazzucato made this week — it specifically recommended patent pooling. Zaitchik notes that optimism was still possible: “Battle-scarred veterans of the medicines-access and open-science movements hoped the immensity of the pandemic would override a global drug system based on proprietary science and market monopolies.”

      Today’s Daily Devil’s Dictionary definition:

      Proprietary science:

      An oxymoron to the extent that “science” simply means human knowledge and cannot be owned or commodified.

      Contextual Note

      The WHO was thus prepared to play the role assigned to its mission as stated in its constitution: “The health of all peoples is fundamental to the attainment of peace and security and is dependent upon the fullest co-operation of individuals and States.” Aware of the challenge lying ahead of them, the team began to prepare its campaign. Alas, it hadn’t counted on the intervention of the globe’s self-appointed Mr. World Health, Bill Gates, whose title derives from his contributing billions of dollars to the causes he believes in (the Bill and Melinda Gates Foundation has invested $1.75 billion in the development and distribution of the COVID-19 vaccine). Among them is the most sacred of all causes: intellectual property. 

      Embed from Getty Images

      Zaitchik describes in detail how Gates — a man with no skills in science, security or politics — has positioned himself to dictate to the world how contemporary science will affect every human being’s security. The key, following the logic of all capitalistic projects, is the management of scarcity. Without scarcity, industry cannot survive and prosper. Little does it matter that because of scarcity many humans simply will not survive.

      Before Gates’s intervention, the group sought “to create a voluntary intellectual property pool inside the WHO.” In so doing, they demonstrated their naivety: “That pharmaceutical companies and their allied governments would allow intellectual property concerns to slow things down — from research and development to manufacturing scale-up — does not seem to have occurred to them.” But that is exactly what happened, thanks to Gates’s overpowering voice (measured by billions of dollars rather than decibels) and his “reputation as a wise, beneficent, and prophetic leader.” When the dust cleared, what emerged was “a zero-sum vaccination battle that has left much of the world on the losing side.”

      Zaitchik documents the ensuing catastrophe due largely to “Gates’s dedication to monopoly medicine” and his “unwavering commitment to drug companies’ right to exclusive control over medical science and the markets for its products.” No one other than powerful governments can hope to compete with Gates’s cash reserves. But Gates’s own government, in Washington, DC, — whether under a Democrat or a Republican president — would never compete as a matter of principle. Competition is a private game. No other government in the world has the power to compete. The US government, like Gates himself, appears addicted to “politically constructed and politically imposed monopolies.”

      Historical Note

      The egregious oxymoron “proprietary science” would have seemed strange to the ears of anyone living before the industrial revolution. Were he alive today and imbued with modern economic culture, the 15th-century German printer, Johannes Gutenberg, would be claiming a percentage of every book, journal or magazine produced thanks to his invention of the printing press. Instead, Adolph II of Nassau, Archbishop of Maintz rewarded Gutenburg — the Bill Gates or Elon Musk of his day — for his innovation “with the title of ‘Gentleman of the Court’.” He also received “a court outfit, a stipend and two tonnes of grain and wine, tax-free.” The wine can be explained by the fact that Gutenberg’s inspiration for the printing press came from observing a wine press.

      Gates deserves to be similarly honored for his invention of MS-DOS. Rather than the billions extracted from the Earth’s entire population thanks to his skill at monopoly creation and predatory business practices, he should have received from the governor of the state of Washington an appropriate title (“Gentleman of the coding room”), a flashy suit of clothes with a matching raincoat (for Seattle weather), a generous stipend (a million of two per year would be appropriate) and maybe an unlimited supply of canned foods, since he is a believer in and expert practitioner of canned economic and scientific wisdom.

      As many of the rest of us queue up for one of the competing vaccines that promise to bail us all out — despite their disparities in performance adding to the confusion created by the incompetence of competitive governments — we should reflect on what all this tells us about an economic system whose vaunted efficiency Gates believes in and practices while using his money and clout to impose it on an unwilling world.

      *[In the age of Oscar Wilde and Mark Twain, another American wit, the journalist Ambrose Bierce, produced a series of satirical definitions of commonly used terms, throwing light on their hidden meanings in real discourse. Bierce eventually collected and published them as a book, The Devil’s Dictionary, in 1911. We have shamelessly appropriated his title in the interest of continuing his wholesome pedagogical effort to enlighten generations of readers of the news. Read more of The Daily Devil’s Dictionary on Fair Observer.]

      The views expressed in this article are the author’s own and do not necessarily reflect Fair Observer’s editorial policy. More

    • 88 Shares129 Views

      in World Politics

      Is India’s Vaccine Diplomacy a Good Idea?

      by

      In terms of numbers, India ranks the third worst after the US and Brazil when it comes to COVID-19 infections. At the time of publishing, the country has recorded over 12.3 million confirmed cases and more than 163,000 deaths. The BBC reports that India is facing a “severe, intensive” second wave of the pandemic. The situation in states like Maharashtra, Gujarat and Punjab has reached alarming proportions.

      How Did India Combat COVID-19 in 2020?

      Last year, Indian Prime Minister Narendra Modi imposed a stringent lockdown that brought economic activity to a shuddering halt. This lockdown led to a dramatic contraction of India’s GDP by 23.9% in the April-June 2020 quarter. The economy recovered somewhat in later quarters, but it experienced a recession in the 2020-21 financial year for the first time in 25 years.

      Arguably, the lockdown was a success in preventing a rapid spread of COVID-19 last year. In percentage terms, India did not do too badly. After all, it has nearly 1.4 billion people in contrast to the US population of 330 million. The daily new cases in India dramatically declined until recently when the second wave hit the country. Thanks to a young population and public health measures, India experienced a remarkably low mortality rate.

      What’s Behind Chile’s Vaccination Success?

      READ MORE

      India has low per capita income and poor health care facilities. So, its achievement in controlling the COVID-19 outbreak has been hailed by many public health experts, including the World Health Organization (WHO). In January, India launched a massive vaccination program to fight the pandemic. This was possible because the country has a track record of mass vaccination and massive vaccine production.

      Indian manufacturers supply more than 60% of the world’s vaccines against diseases like polio and measles. Early on, the country began mass production of two COVID-19 vaccines: Covishield and Covaxin. The Serum Institute of India (SII), which partnered with the University of Oxford and AstraZeneca, had already produced and stocked approximately 70 million Covishield doses even before India granted emergency approval to their vaccine. 

      On January 16, India launched an ambitious plan to vaccinate around 300 million people by June. The world’s largest vaccination program focused first on those with high vulnerability to the coronavirus. First on the list were health care workers. They were followed by those who were 65 years or older. This ensured that the vaccine was not monopolized by the richest sections of Indian society. 

      As vaccinations have increased, the Modi government has eased restrictions in the country. Crowds have gathered at large weddings, sporting events and festival celebrations. The government lifted restrictions to stimulate economic activity. A poor country like India with a large population could not afford a lockdown for too long. However, the easing of restrictions has not only led to increased economic growth, but also rising cases of COVID-19 infections. India faces a tough balancing act between stimulating economic activity and curtailing a pandemic.

      India’s Vaccine Diplomacy

      During the pandemic, India has embarked on an ambitious foreign policy initiative. Modi announced the Vaccine Maitri initiative to supply COVID-19 vaccines to other nations only four days after India began domestic vaccinations. With the world’s largest manufacturer of vaccines, India has shipped approximately 61 million doses to 84 countries, which have included free batches. It has pledged 200 million doses for the WHO’s COVID-19 Vaccines Global Access (COVAX) initiative to ensure vaccines for 92 low and middle-income countries.

      Embed from Getty Images

      India began its vaccine diplomacy by distributing doses to its immediate neighbors: Nepal, Bangladesh, Sri Lanka and the Maldives. The country has also exported vaccines to faraway places such as the Caribbean, where the likes of Barbados, Dominica and Jamaica have benefited from Indian aid. Leaders of countries such as Brazil and Antigua and Barbuda have publicly thanked Modi for his country’s generosity.

      As per some foreign policy experts, India’s vaccine distribution is a diplomatic masterstroke. It helps the country gain goodwill and increase its soft power. It could lead to a more peaceful neighborhood. In the future, India might win much support, strengthen its claim to a permanent seat at the UN Security Council and emerge as a great world power.

      Vaccine diplomacy might be giving a rare chance to counter China, which has launched the Belt and Road Initiative to increase its global footprint. For decades, China has backed Pakistan and, for the last few years, has increased its presence in Myanmar, Bangladesh, Sri Lanka and Nepal. With Chinese influence growing in India’s closest neighbors, the country has understandably become anxious.

      In June 2020, Chinese and Indian troops engaged in a bloody hand-to-hand combat with many dying in the process. Since that clash, relations between India and China have been fraught. India has banned over 200 Chinese apps and restricted Chinese investment into the country. COVID-19 has given a unique opportunity to India — the “pharmacy of the world” — to compete with China. By shipping vaccines to low and middle-income countries, India is gaining influence at the Chinese expense whose vaccines have been questioned by Western media.

      Rich countries have failed poorer ones because they have focused on domestic programs. Unlike India, the United States, the European Union and the United Kingdom are focused completely on vaccinating their domestic populations. India’s generosity is unique and might lead to long-term gains.

      Masterstroke or Distraction?

      However, there is a counterargument that India has been premature in kicking off vaccine diplomacy. It did so before setting its own house in order. According to the Johns Hopkins Coronavirus Resource Center, as of April 2, India has administered nearly 69 million doses, fully inoculating only 9.6 million people. That is just 0.71% of its population. India’s focus should have been getting every one of its citizens vaccinated instead of basking in complimentary tweets from foreign leaders. Such goodwill might turn out to be very transient. 

      Recently, India has slowed down its vaccine exports and speeded up its vaccination program. The government has now enrolled private hospitals in its vaccination drive, and everyone above the age of 45 is now eligible for the vaccine. Modi himself got vaccinated on March 1, boosting public faith in COVID-19 vaccines and increasing their uptake nearly four-fold. It seems that the government is paying attention to its critics.

      Time will tell whether India’s vaccine diplomacy was a bold masterstroke or an unwise distraction. It reveals that there are no easy choices for any nation during a raging pandemic.

      The views expressed in this article are the author’s own and do not necessarily reflect Fair Observer’s editorial policy. More

    • 63 Shares159 Views

      in World Politics

      Wealth Inequality Breeds Health Inequality

      by

      In an AP article last December, Maria Cheng and Aniruddha Ghosal noted that, despite official optimism concerning the capacity of emerging vaccines to provoke the definitive decline of the COVID-19 pandemic, “the chances that coronavirus shots will be shared fairly between rich nations and the rest are fading fast.” Their fears have been confirmed.

      How Stable Is Antony Blinken’s Idea of Stability?

      READ MORE

      Natasha Frost at The New York Times reports on how wealth inequality has led to vaccine inequality, with the potentially disastrous effect of prolonging an already year-old global pandemic. She blames the various political establishments that have allowed this to happen. “It didn’t have to be like this,” she writes. “Western governments have resisted the call from global health officials to use rarely employed aggressive powers that could have forced companies to publish vaccine recipes, share their knowledge and ramp up manufacturing, in turn leading to broader vaccine access.”

      Today’s Daily Devil’s Dictionary definition:

      Aggressive powers:

      Special tools of government designed to address real, serious and urgent problems, sometimes mobilized to prosecute wars, but never employed to modify practices that might compromise the prospect of profit by private companies

      Contextual Note

      Military aggression (invasion, war, bombing campaigns) and economic aggression (sanctions, embargoes, boycotts) are the two policy instruments contemporary governments privilege to defend what they deem to be their “national interest.” Democratic nations continue to claim, against all evidence, that aggressive and fundamentally destructive actions taken against other peoples or nations — to kill, maim or simply create economic deprivation — are efficient means designed to protect their own people’s interest. Since commercial media never question this logic, discussion of what “national interest” implies never even enters the public’s field of awareness. War and sanctions sound virile and so must be good. 

      Embed from Getty Images

      Whereas the English language has easily accepted “military aggression” and “economic aggression” as useful descriptive terms, the idea of “health aggression” has no place in anyone’s vocabulary. Health is not something the political infrastructure believes it can or should do anything “aggressive” about. It is both too personal and too profitable. In the US in particular, health is not considered to be something to strive for, but simply as a marketplace in which, as Cole Porter once said, anything goes (to make a profit).

      In an AP article by Cheng and Lori Hinnant that appeared earlier this month, the authors explain that the marketing policies of pharmaceutical companies are the source of what is quickly becoming a desperate situation for the majority of humankind. Companies “that took taxpayer money from the U.S. or Europe to develop inoculations at unprecedented speed say they are negotiating contracts and exclusive licensing deals with producers on a case-by-case basis because they need to protect their intellectual property and ensure safety.”

      Any rational human being with a basic understanding of language should be shocked by two words in the concluding phrase of that sentence. The first is “their.” The companies believe they exclusively own what a community built and paid for. Analyzing the logic of a supply chain and production line makes it clear that the areas they have invested in turn out to be testing, redesign, packaging and delivery. These are important features of any product. But they do not justify the claim of exclusive ownership.

      The second shocking term is “safety.” The firms deem themselves protectors of their customers’ “safety.” Their role in the process of combating the virus consists of refining the product and testing it to meet public safety standards. But the marketing attitude that guides their actions continues to privilege the idea of hoarding, seeking monopolistic advantage and exploiting scarcity in a marketplace. This poses a serious risk of undermining public safety and preventing the coordinated action that alone could lead to the elimination of a global pandemic.

      Historical Note

      During the discussions to fund the vaccines, the private companies selected for the honor of producing the vaccines destined to save the world in all probability declined to take on the burden without the assurance that the research would be fully funded and the intellectual property (IP) would be assigned to them as a guarantee of future profit. The politicians who accepted those terms were undoubtedly guided by the wisdom of the economics 101 course they attended decades ago in their youth that taught them how the focus on profit is the key to economic efficiency. The higher the profit, the greater the efficiency, they were told.

      In the past four decades, this logic has even been applied to the universities that offered those courses. They have become profit-focused institutions, dedicated to supporting the bloated salaries of the administration that “ensures” efficiency rather than the educational vocation of the institution.

      Today’s drama could stand as a model lesson for a future economics 101 course, though few would imagine that profit-driven universities will be very keen on the update. If the universities refuse, it should be taught in every high-school civics class on earth. Economics 101.1 would emphasize the perversity of an economic system that forces ordinary citizens in wealthy countries to finance through taxes the research that their government will then donate to private companies that, in turn, will inevitably claim the IP without ever investing a penny of their own money.

      This pattern of socializing private companies and endowing them with product lines that ensure massive future profits through monopolistic exploitation is not limited to the pharmaceutical sector. The giants of Silicon Valley have grown into mastodons who control not just their highly-profitable marketplace, but also people’s lives (their behavior) and minds (their thoughts), thanks to the same process.

      How did we get to this point? To answer that question would require an encyclopedia delving into questions of finance, technology, politics and culture. One obvious factor is the triumph of the idea of globalization that became an article of faith for all “serious thinkers” and most politicians in recent decades. Thomas Friedman famously summed it up with the idea that “the world is flat.” It turns out that when the only recognized motivator of any kind of action concerning human health and safety — or indeed anything else — is money and profit, any other of the needs we expect the economy to address become secondary. In classic economics, a situation of needs not being met will create the demand that a new enterprise will seek to fulfil.

      .custom-post-from {float:right; margin: 0 10px 10px; max-width: 50%; width: 100%; text-align: center; background: #000000; color: #ffffff; padding: 15px 0 30px; }
      .custom-post-from img { max-width: 85% !important; margin: 15px auto; filter: brightness(0) invert(1); }
      .custom-post-from .cpf-h4 { font-size: 18px; margin-bottom: 15px; }
      .custom-post-from .cpf-h5 { font-size: 14px; letter-spacing: 1px; line-height: 22px; margin-bottom: 15px; }
      .custom-post-from input[type=”email”] { font-size: 14px; color: #000 !important; width: 240px; margin: auto; height: 30px; box-shadow:none; border: none; padding: 0 10px; background-image: url(“https://www.fairobserver.com/wp-content/plugins/moosend_form/cpf-pen-icon.svg”); background-repeat: no-repeat; background-position: center right 14px; background-size:14px;}
      .custom-post-from input[type=”submit”] { font-weight: normal; margin: 15px auto; height: 30px; box-shadow: none; border: none; padding: 0 10px 0 35px; background-color: #1878f3; color: #ffffff; border-radius: 4px; display: inline-block; background-image: url(“https://www.fairobserver.com/wp-content/plugins/moosend_form/cpf-email-icon.svg”); background-repeat: no-repeat; background-position: 14px center; background-size: 14px; }

      .custom-post-from .cpf-checkbox { width: 90%; margin: auto; position: relative; display: flex; flex-wrap: wrap;}
      .custom-post-from .cpf-checkbox label { text-align: left; display: block; padding-left: 32px; margin-bottom: 0; cursor: pointer; font-size: 11px; line-height: 18px;
      -webkit-user-select: none;
      -moz-user-select: none;
      -ms-user-select: none;
      user-select: none;
      order: 1;
      color: #ffffff;
      font-weight: normal;}
      .custom-post-from .cpf-checkbox label a { color: #ffffff; text-decoration: underline; }
      .custom-post-from .cpf-checkbox input { position: absolute; opacity: 0; cursor: pointer; height: 100%; width: 24%; left: 0;
      right: 0; margin: 0; z-index: 3; order: 2;}
      .custom-post-from .cpf-checkbox input ~ label:before { content: “f0c8”; font-family: Font Awesome 5 Free; color: #eee; font-size: 24px; position: absolute; left: 0; top: 0; line-height: 28px; color: #ffffff; width: 20px; height: 20px; margin-top: 5px; z-index: 2; }
      .custom-post-from .cpf-checkbox input:checked ~ label:before { content: “f14a”; font-weight: 600; color: #2196F3; }
      .custom-post-from .cpf-checkbox input:checked ~ label:after { content: “”; }
      .custom-post-from .cpf-checkbox input ~ label:after { position: absolute; left: 2px; width: 18px; height: 18px; margin-top: 10px; background: #ffffff; top: 10px; margin: auto; z-index: 1; }
      .custom-post-from .error{ display: block; color: #ff6461; order: 3 !important;}

      Our pundits and economic thinkers imagine that, in a global economy, the process will be even more efficient because competition can come from any direction and supply chains can be easily reconfigured. In no time at all, the needs will be effectively and efficiently addressed. But the conditions for any new competitor to realize such a scenario require three largely unattainable conditions: extravagant funding to attain a scale of credible performance, recognition by public authorities (which often requires prior contributions to their political campaigns), and the belief in the possibility of a monopolistic position. 

      Guaranteed monopoly is the hardest to achieve for a newcomer, which is why over the past two decades, pundits have highlighted the necessity of disruptive innovation. This generally means focusing on a specific market opportunity rather than addressing a fundamental need. It also means that if the need is global, there is absolutely no chance of a newcomer having an impact. The major players are safe from new competition. Disruptive innovation is a wonderful way to spawn new gadgets or convenience products. Unfortunately, global societal needs require global societal reflection, research, coordination and concerted action.

      During the wars of the 20th century, democratic nations mobilized the “aggressive powers” provided by their laws to respond to the emergency of global conflict. This posed no challenge to the principles of democracy, where all shared the idea that such measures were required for the safety of the national population. War profiteering existed, since any intense effort creates new areas of economic opportunity, but governments were guided by the collective needs of the nation. They refused to allow policy to be dictated by the profiteers.

      With the first of what may become a series of pandemics converging with an impending global climate crisis, it might just be time for politicians to show their aggression by putting public safety ahead of private profit, even if it means revising the syllabus of economics 101.

      *[In the age of Oscar Wilde and Mark Twain, another American wit, the journalist Ambrose Bierce, produced a series of satirical definitions of commonly used terms, throwing light on their hidden meanings in real discourse. Bierce eventually collected and published them as a book, The Devil’s Dictionary, in 1911. We have shamelessly appropriated his title in the interest of continuing his wholesome pedagogical effort to enlighten generations of readers of the news. Read more of The Daily Devil’s Dictionary on Fair Observer.]

      The views expressed in this article are the author’s own and do not necessarily reflect Fair Observer’s editorial policy. More

    • 175 Shares159 Views

      in UK Politics

      No decision yet on whether UK children will get Covid vaccine, says government adviser

      by

      No final decisions have been made on vaccinating children in the UK against Covid-19, a member of the government’s vaccine taskforce has said.It follows a report claiming that Boris Johnson’s government is considering a plan to begin giving Covid jabs to under-18s as early as August 2021.Professor Adam Finn, who sits on the Joint Committee on Vaccination and Immunisation (JCVI), said more studies would be needed before decisions are made about extending the rollout to children.Asked if under-18s could be vaccinated this autumn, Prof Finn told Good Morning Britain: “As far as I know there has been no decision made to immunise children starting in August, or indeed any decision been taken to immunise children at all at this point.”However, the University of Bristol expert said it could become necessary to vaccinate children later this year – and suggested teenagers would be the priority. “It’s certainly something that we might need to do,” he added.“If it does turn out to be necessary to immunise children, I think it is more likely that we would prioritise teenagers over younger children, simply because the evidence we have at the moment is that transmission of the virus is more likely to occur from and between teenagers who are a little bit more like adults.”The government is making provisional plans to begin immunising children as early as August, according to a report in The Daily Telegraph on Wednesday, which cited two sources involved in preparations. More

    • 100 Shares169 Views

      in World Politics

      Why the US Return to the WHO Matters

      by

      In compliance with major statements made repeatedly during his electoral campaign, US President Joe Biden, on his first day in office on January 20, signed two important executive orders — among 15 others, a record number — signaling the United States’ return to the international arena, to global cooperation and multilateralism. One of these orders was for the United States to rejoin the 2015 Paris Agreement on climate change, and the other was to reestablish the country’s full membership and support to the World Health Organization (WHO).

      Germany’s Handling of the Pandemic: A Model of Incompetence?

      READ MORE

      Both acts were hugely symbolic, especially since they occurred within hours of Biden’s inauguration, as they set a fundamentally new tone in US foreign policy and sent a strong signal to the world, paraphrased as: We are back, count on us. But other than being symbolic, these acts constitute a material and substantial backing of global efforts to address two of the 21st century’s most severe world crises — the COVID-19 pandemic and climate change — under the aegis of the United Nations.

      When the Trump administration announced in July 2020, in the middle of the most devastating pandemic in at least a century, that the US would withdraw from the WHO — having already frozen payments of mandatory membership dues and thereby violating international law months earlier — that move was widely regarded as not only hugely counterproductive but as outright insane.

      The World Needs the US as Well

      Clearly, the country hit hardest by the pandemic — both in terms of total infections and deaths — is better off as a member of the very global community that ensures the fast sharing of research, data and best practices, coordinates responses, and comes together to devise evidence-based solutions to the world’s most pressing public health issues, be it malaria, tuberculosis, HIV or COVID-19. But the international community needs the US as well.

      Embed from Getty Images

      In fact, the US has been the single most important independent variable in international relations and global affairs since President Franklin D. Roosevelt’s signing of the Declaration of the United Nations on January 1, 1942. Hence, a WHO without the active participation and support of the US government is unthinkable. This engagement extends well beyond funding. Since its inception in 1948, the US has been the single largest contributor to the WHO — which budgeted $4.84 billion for the biennium 2020-21, not including COVID-19-related expenses — with a steady share of 22% of the organization’s assessed core budget and significant additional voluntary contributions made every single year.

      Yet the active support of medical research data, analysis, know-how, logistics, supplies and people power to the WHO’s multifold programs and emergency operations by the US, such as during the West African Ebola crisis of 2013-15, is priceless and virtually irreplaceable. Indeed, a great sense of relief was voiced in unison by scientists, senior government officials and UN leaders alike when the Biden administration applied common sense and restored the United States’ bond with the WHO on the day of its inception. This step will have an immediately relevant and measurable impact on the global response to SARS-CoV-2, the virus that causes COVID-19.

      With the unfreezing of previously withheld payments and the allocation of additional, fresh sums of money targeted at global health emergency relief efforts, research and development, and the provision of supplies and teams, the global fight against COVID-19 will experience an important boost. This will be particularly important in the context of WHO’s COVAX initiative, which is a historic, unprecedented fundraising effort to make effective and safe vaccines available to all countries, especially developing ones. Moreover, COVAX entails a proprietary vaccine development program, including the building of manufacturing capabilities, and provides technical and logistical support to countries in need.

      COVAX Initiative

      The new US administration has quickly become COVAX’s largest funder and pledged to donate surplus vaccine stocks in addition to its financial contributions. Also, efforts to assist developing countries by deploying on-the-ground technical assistance where needed are underway.

      However, COVAX still has a long way to go to meet its goal of buying supply so that 2 billion doses can be fairly and equitably distributed by the end of 2021. To date, financial support by OECD countries to the facility has been lukewarm at best, although the US and Germany stand out. The apparent lack of solidarity and tangible support by wealthy nations is disappointing and recently prompted UN Secretary-General Antonio Guterres to call global vaccine distribution “wildly uneven and unfair,” describing the goal of providing vaccines to all as “the biggest moral test before the global community.”

      In the case of the COVID-19 pandemic with its rapidly-emerging mutations and variants, quick, unequivocal and substantial support — both financial and technical — to developing countries and those behind in getting access to effective vaccines is not only a moral obligation for developed countries, but also a mere matter of rationality and self-interest.

      As long as over 100 countries globally have not even received a single dose of a COVID-19 vaccine, even the most ambitious and aggressive vaccine rollout campaigns in wealthy countries may be in vain as new variants of SARS-CoV-2 can emerge and cause new viral strains at any time. The Biden administration, along with other governments, is well advised to massively support multilateral solutions and collective action. It is the only reasonable, promising approach to tackling the world’s biggest crises in the 21st century.

      *[This article was submitted on behalf of the author by the Hamad bin Khalifa University Communications Directorate. The views expressed are the author’s own and do not necessarily reflect the university’s official stance.]

      The views expressed in this article are the author’s own and do not necessarily reflect Fair Observer’s editorial policy. More